Difference between revisions of "CD30"
Jump to navigation
Jump to search
m (update address) |
(tweak) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
*[[Hodgkin lymphoma]]. | *[[Hodgkin lymphoma]]. | ||
*[[Embryonal carcinoma]]. | *[[Embryonal carcinoma]]. | ||
==Negative staining== | |||
*[[Seminoma]]. | |||
**CD30 positive seminoma with keratin staining reported.<ref name=pmid8912826>{{cite journal |authors=Hittmair A, Rogatsch H, Hobisch A, Mikuz G, Feichtinger H |title=CD30 expression in seminoma |journal=Hum. Pathol. |volume=27 |issue=11 |pages=1166–71 |date=November 1996 |pmid=8912826 |doi=10.1016/s0046-8177(96)90310-x |url=}}</ref> | |||
==References== | |||
{{Reflist|1}} | |||
==External links== | ==External links== | ||
Latest revision as of 17:10, 25 March 2021
CD30 is common immunostain that is available in many labs.
Positive staining
Negative staining
References
- ↑ Hittmair A, Rogatsch H, Hobisch A, Mikuz G, Feichtinger H (November 1996). "CD30 expression in seminoma". Hum. Pathol. 27 (11): 1166–71. doi:10.1016/s0046-8177(96)90310-x. PMID 8912826.